NCT00159744View on ClinicalTrials.gov

3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)

PHASE3CompletedINTERVENTIONAL

Enrollment

488

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

April 29, 2006

Study Completion Date

April 29, 2006

Conditions

Bipolar Disorder

Interventions

DRUG

Asenapine

Asenapine, 3 weeks

DRUG

Olanzapine

Olanzapine, 3 weeks

DRUG

Placebo

placebo, 3 weeks

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Organon and Co

INDUSTRY